Home|Journals|Articles by Year|Audio Abstracts
 

Original Research

Egypt. J. Exp. Biol. (Zoo.). 2007; 3(0): 101-111


EFFECT OF GINGER ON MANCOZEB FUNGICIDE-INDUCED HISTOLOGICAL AND HISTOCHEMICAL CHANGES IN THYROID GLAND OF ALBINO RAT

Saber A. Sakr, Yosry A. Okdah, Eman K. El-Adly.




Abstract

Mancozeb is an ethylene-bis-dithiocarbamate (EBDC) fungicide. It is used in a wide range to control several of fungal diseases in field crops and fruits. Administration of mancozeb at a dose level of 1/10 LD50 3 times / week for six weeks induced marked histological and histochemical changes in thyroid gland of albino rat. The histological changes included dilation and congestion in blood vessels of the interstitum, atrophy of many follicular cells and hyper trophy of the parafollicular cells, decrease in the amount of colloid and cytoplasmic vacuolation in the follicular cells. The histochemical changes appeared as decrease in both PAS positive materials and protein contents. Ginger (Zingiber officinale) is a monocotyledonous plant with many pharmacological properties. Treating animals with ginger extract induced improvements in both the histological and histochemical changes induced by mancozeb in the thyroid gland. These results proved that ginger had inhibitory effects against thyroid toxicity induced by mancozeb.

Key words: Ginger, Mancozeb Fungicide Histologogy, Histochemistry, Thyroid Gland, Albino Rat






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Author Tools
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.